28. Systemic amyloidosis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 335 / Drugs : 274 - (DrugBank : 86) / Drug target genes : 47 - Drug target pathways : 165
Other names | - | ||
---|---|---|---|
Disease group | Metabolic diseases | ||
Domestic patients
Med expenses recipients (FY2023) |
6,817 patients Age distribution
![]() |
||
Related info (in Japanese) | - | ||
Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 028-01, 028-02, 028-03, 028-04 | ||
Specific pediatric chronic diseases, Japan (in Japanese) | - | ||
Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
28-1. | Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis; | ||
28-2. | Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA; | ||
28-3. | Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP; | ||
28-4. | Hereditary systemic amyloidosis; |